000298944 001__ 298944
000298944 005__ 20250223015325.0
000298944 0247_ $$2doi$$a10.1136/bmjopen-2024-085456
000298944 0247_ $$2pmid$$apmid:39956597
000298944 0247_ $$2pmc$$apmc:PMC11831281
000298944 0247_ $$2altmetric$$aaltmetric:174303934
000298944 037__ $$aDKFZ-2025-00378
000298944 041__ $$aEnglish
000298944 082__ $$a610
000298944 1001_ $$aPrue, Gillian$$b0
000298944 245__ $$aModels of care and associated targeted implementation strategies for cancer survivorship support in Europe: a scoping review protocol.
000298944 260__ $$aLondon$$bBMJ Publishing Group$$c2025
000298944 3367_ $$2DRIVER$$aarticle
000298944 3367_ $$2DataCite$$aOutput Types/Journal article
000298944 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1739889959_9494$$xReview Article
000298944 3367_ $$2BibTeX$$aARTICLE
000298944 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000298944 3367_ $$00$$2EndNote$$aJournal Article
000298944 520__ $$aCancer and its treatments can lead to a wide range of side-effects that can persist long after treatments have ended. Across Europe, survivorship care is traditionally hospital-based specialist-led follow-up, leading to gaps in supportive care. Improved screening, diagnosis and treatment increase survival rates. With more individuals living with, through and beyond cancer, the predominance of the hospital-based specialist model is unsustainable, costly and resource-intensive. An understanding of what alternative Models of Care are available and the barriers and facilitators to their implementation is a first step towards enhancing supportive care across the cancer journey. The aim of this scoping review is to source and synthesise information from studies evaluating patient-oriented models of cancer survivorship supportive care for adults in Europe.The scoping review will be reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses-Scoping Review Extension guidelines and will be guided by a six-stage methodological framework. A search strategy has been developed according to the Population, Concept and Context structure and will be applied to seven databases. A targeted search of grey literature will be completed. All identified records will be screened using predefined eligibility criteria by at least two researchers and undergo full-text review for inclusion. Data pertaining to the conceptualisation, evaluation and implementation of sourced Models of Care will be extracted.As there is no primary data, ethical approval is not required. This review will be conducted as part of the EU COST Action CA21152-Implementation Network Europe for Cancer Survivorship Care. The protocol and subsequent scoping review will be published in a peer-reviewed journal. The Action involves representatives from most countries across Europe which will assist with the dissemination of the work to key stakeholders.
000298944 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000298944 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000298944 650_7 $$2Other$$aDelivery of Health Care, Integrated
000298944 650_7 $$2Other$$aHealth Services
000298944 650_7 $$2Other$$aHealth policy
000298944 650_7 $$2Other$$aInternational health services
000298944 650_7 $$2Other$$aPatient-Centered Care
000298944 650_7 $$2Other$$aReview
000298944 650_2 $$2MeSH$$aHumans
000298944 650_2 $$2MeSH$$aEurope
000298944 650_2 $$2MeSH$$aCancer Survivors
000298944 650_2 $$2MeSH$$aNeoplasms: therapy
000298944 650_2 $$2MeSH$$aResearch Design
000298944 650_2 $$2MeSH$$aSurvivorship
000298944 7001_ $$aCzamanski-Cohen, Johanna$$b1
000298944 7001_ $$aKassianos, Angelos P$$b2
000298944 7001_ $$00000-0001-7146-4740$$aPilleron, Sophie$$b3
000298944 7001_ $$aLadas, Aristea$$b4
000298944 7001_ $$aAkcakaya Can, Aysun$$b5
000298944 7001_ $$00000-0002-7355-9740$$aRoldán-Jiménez, Cristina$$b6
000298944 7001_ $$aDegi, Csaba Laszlo$$b7
000298944 7001_ $$aIşcan, Gökçe$$b8
000298944 7001_ $$aArslan, Sevban$$b9
000298944 7001_ $$ade Boer, Angela G E M$$b10
000298944 7001_ $$aCelebic, Aleksandar$$b11
000298944 7001_ $$aDoñate-Martínez, Ascensión$$b12
000298944 7001_ $$aAlhambra-Borrás, Tamara$$b13
000298944 7001_ $$aMitrevski, Boce$$b14
000298944 7001_ $$aMarzorati, Chiara$$b15
000298944 7001_ $$aPravettoni, Gabriella$$b16
000298944 7001_ $$aGrasso, Roberto$$b17
000298944 7001_ $$aNazik, Evsen$$b18
000298944 7001_ $$aPawlowska, Ewa$$b19
000298944 7001_ $$aMucalo, Iva$$b20
000298944 7001_ $$aBrowne, John Patrick$$b21
000298944 7001_ $$aTripkovic, Katica$$b22
000298944 7001_ $$aVojvodic, Katarina$$b23
000298944 7001_ $$aKarekla, Maria$$b24
000298944 7001_ $$aMoschofidou, Maria$$b25
000298944 7001_ $$aBayram, Sule Biyik$$b26
000298944 7001_ $$aBrandão, Tânia$$b27
000298944 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b28$$udkfz
000298944 7001_ $$aJaswal, Poonam$$b29
000298944 7001_ $$aSemerci, Remziye$$b30
000298944 7001_ $$aBozkul, Gamze$$b31
000298944 7001_ $$aSahin, Eda$$b32
000298944 7001_ $$aToygar, Ismail$$b33
000298944 7001_ $$aFrountzas, Maximos$$b34
000298944 7001_ $$aMartins, Rui Miguel$$b35
000298944 7001_ $$aJefford, Michael$$b36
000298944 7001_ $$00000-0002-2355-2567$$aKeane, Danielle$$b37
000298944 7001_ $$aHegarty, Josephine$$b38
000298944 773__ $$0PERI:(DE-600)2599832-8$$a10.1136/bmjopen-2024-085456$$gVol. 15, no. 2, p. e085456 -$$n2$$pe085456$$tBMJ open$$v15$$x2044-6055$$y2025
000298944 909CO $$ooai:inrepo02.dkfz.de:298944$$pVDB
000298944 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b28$$kDKFZ
000298944 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000298944 9141_ $$y2025
000298944 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMJ OPEN : 2022$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-01-24T13:10:16Z
000298944 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-01-24T13:10:16Z
000298944 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review$$d2024-01-24T13:10:16Z
000298944 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-19
000298944 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-19
000298944 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000298944 980__ $$ajournal
000298944 980__ $$aVDB
000298944 980__ $$aI:(DE-He78)C071-20160331
000298944 980__ $$aUNRESTRICTED